We have shortened the time to diagnosis, improved care, identified new treatment options, and improved quality of life and long-term outcomes.

Your dollars at work:

• $23 million invested in improving juvenile myositis research, care, and support.

• Finding better treatments with fewer side effects including baricitinib, deucravacitinib, and vamorolone

• 30 juvenile myositis specialists part of Cure JM's Clinical Care network to ensure kids get the best care.

• Early diagnosis and education program helping reduce typical diagnosis time from more than 18 months to less than 4 months. Early diagnosis and treatment improves outcomes.

• Creating 20 chapters to bring patients, families, and clinicians together --- because we are stronger together!

• Providing medical training to pediatric rheumatologists, creating more JM specialists and improving outcomes

• Providing education to more than 2,500 clinicians and researchers to ensure distribution of the latest information in treatment and diagnosis protocols.

• Recruiting leading JM doctors and researchers to our Medical Advisory Board, meaning that we have the “best of the best” as our partners in medical progress.

Thanks to you, children today are doing better than ever before.

But we still have more work to do. There are now more new treatments in development than ever before.

Your support gives children a brighter future.